BioPharmSignal logoBioPharmSignal

Biotech News

Transactions of Managers and Closely Associated Persons

Alvotech (ALVO)AlvotechFinancing

Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the pledging...

Read More

July 01, 2026 04:00 ET | Source: Alvotech

$75 million additional term loan facility maturing December 31, 2027, led by GoldenTree Asset ManagementFollows recent $165m equity raise strengthening cash positionIncluding equity financing and...

Read More

Related news

ALVOAlvotech2026-06-18 09:51 EST

Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement

ALVOAlvotech2026-06-16 03:59 EST

Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement

MDXGMiMedx2026-02-04 15:28 EST

MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products

CHRSCoherus BioSciences, Inc.2026-02-17 21:11 EST

Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock

IBIOIbio Inc2026-01-09 12:00 EST

iBio Announces $26 Million Private Placement

CHRSCoherus BioSciences, Inc.2026-02-13 02:18 EST

Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock

AZNAstraZeneca PLC2016-11-01 15:30 EST

Dealing by Person Closely Associated

AMRXAmneal Pharmaceuticals2026-06-29 07:00 EST

Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations

View all latest news

Alvotech

Alvotech is a biosimilars company developing and manufacturing lower-cost alternatives to complex biologic medicines.

Recent company news

ALVOAlvotech2026-07-03 20:01 EST

Viðskipti stjórnenda og tengdra aðila

ALVOAlvotech2026-07-03 20:01 EST

Transactions of Managers and Closely Associated Persons

ALVOAlvotech2026-07-01 08:00 EST

Alvotech styrkir lausafjárstöðu sína enn frekar með aðgengi að 75 milljóna dala lánsfjármögnun

ALVOAlvotech2026-07-01 08:00 EST

Alvotech further strengthens liquidity by securing term loan facility of $75 million

ALVOAlvotech2026-06-22 22:48 EST

Viðskipti stjórnenda og tengdra aðila

Stock data

Close
3.08 USD
Market cap
936.14M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States